$KR

Kroger (KR) Q2 2026 Earnings Call Transcript

Kroger (KR) reported Q2 2026 adjusted earnings per diluted share of $1.09, highlighting operational strengths amid industry challenges. The company emphasized cost savings, e-commerce growth (up 20%), and retail media growth (up 24%). Kroger also expanded its natural and organic offerings, launched a grocery and prescription delivery service, and introduced new executive leadership. Despite consumer budget pressures, the company saw strong engagement in health-focused products and private-label

Original reporting
Published Sep 12, 2026, 3:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 12, 2026, 3:20 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Kroger (KR) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$KRBullishMed
01

Why it matters

The earnings beat and ecommerce growth suggest near‑term upside, but margin pressure from higher costs could limit upside.

02

Market read

Kroger's results provide a benchmark for the grocery sector's resilience and ecommerce trajectory.

03

What to watch

Potential headwinds from SNAP benefit cuts and higher fuel prices may dampen future growth.

Relevance 8/10Novelty 8/10Timing: post‑market release

Background

Kroger's earnings call discussed operational execution, cost savings, and strategic ecommerce initiatives amid a challenging consumer environment.

Company-level read

Ticker impact

$KRBullishHigh confidence
Context

Kroger reported Q2 2026 adjusted earnings of $1.09 per diluted share and highlighted growth in ecommerce sales and retail media.

Expected impact

Potential modest rally in pre‑market trading.

Evidence & confidence

Large‑cap retailer with better‑than‑expected EPS and notable ecommerce acceleration; investors typically reward such beats.

Market effects

Positive signal for grocery and retail sector, especially for peers focusing on ecommerce.

U.S. consumer discretionary stocks may see modest lift.

Limited to U.S. market; no direct global impact.

Counterpoint

If guidance is weak or cost pressures rise, the rally could be short‑lived.

Key entities

  • Emily DeMartino

    New chief people officer.

  • Nate Faust

    Executive vice president and chief ecommerce officer.

  • Mary Ibbotson

    Executive vice president and chief store operations officer.

Related articles

$KRMed

Stocks Bounce Back After Oil Price Drop, Inflation Report

US stocks rebounded Friday, with the Dow, S&P 500, and Nasdaq gaining 1%, 0.9%, and 1% respectively, despite weekly losses. Oil prices fell 2.8% to $104.61, easing inflation concerns. US consumer prices rose 3.4% year-over-year, close to expectations. Kroger gained 2.7% on strong earnings, ACV Auctions soared 44.2% on a Copart acquisition offer, and Oracle fell 1.7% after an initial surge.

$KRMedAI 8/10

Kroger cuts same-store sales outlook for 2026

Kroger reduced its 2026 same-store sales growth forecast to 0.2%-0.8%, down from 1%-2%, citing the Inflation Reduction Act's 140 basis point impact. Q2 sales grew 0.2% excluding fuel, missing estimates. Total sales were $34.6B. Earnings per share guidance remains $5.10-$5.30. Ecommerce sales rose 20%, and retail media revenues increased 24%.

$KRHighAI 8/10

Kroger Slashes Outlook as Strained Consumers Pivot

Kroger (KR) lowered its full-year guidance for identical sales without fuel to 0.2% to 0.8%, down from 1.0% to 2.0%, citing consumer pressure and other factors. Q2 sales growth slowed to 0.2% from 3.4% in 2025. CEO Foran and CFO Kennerley attributed the decline to macroeconomic challenges, including reduced SNAP benefits and higher fuel prices, as well as specific issues like the Inflation Reduction Act and a cyclospora outbreak.

$KRMedAI 8/10

The Kroger Co. Q2 2026 Earnings Call Summary

Kroger reported Q2 2026 earnings, citing cost savings and e-commerce growth offsetting challenges. Identical sales were impacted by a Cyclospora outbreak and pharmacy headwinds. Full-year guidance lowered to 0.2%–0.8%. Management emphasized strategic shifts in leadership, operational improvements, and a focus on private label brands. Share repurchases totaled $1.2B in H1, with $800M remaining. The company expects inflation pressures in H2 and plans to complete the Giant Eagle acquisition in 2027